DE06722936T8 - Isomerisation pharmazeutischer zwischenprodukte - Google Patents

Isomerisation pharmazeutischer zwischenprodukte Download PDF

Info

Publication number
DE06722936T8
DE06722936T8 DE06722936T DE06722936T DE06722936T8 DE 06722936 T8 DE06722936 T8 DE 06722936T8 DE 06722936 T DE06722936 T DE 06722936T DE 06722936 T DE06722936 T DE 06722936T DE 06722936 T8 DE06722936 T8 DE 06722936T8
Authority
DE
Germany
Prior art keywords
isomerisation
intermediate products
pharmaceutical intermediate
pharmaceutical
products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE06722936T
Other languages
English (en)
Other versions
DE06722936T1 (de
Inventor
Michael Peter Folkmann
Erik Tomgaard Hansen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Pharma AS
Original Assignee
Leo Pharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma AS filed Critical Leo Pharma AS
Publication of DE06722936T1 publication Critical patent/DE06722936T1/de
Application granted granted Critical
Publication of DE06722936T8 publication Critical patent/DE06722936T8/de
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B37/00—Reactions without formation or introduction of functional groups containing hetero atoms, involving either the formation of a carbon-to-carbon bond between two carbon atoms not directly linked already or the disconnection of two directly linked carbon atoms
    • C07B37/08—Isomerisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C07F7/1872—Preparation; Treatments not provided for in C07F7/20
    • C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicinal Preparation (AREA)
DE06722936T 2006-03-17 2006-05-08 Isomerisation pharmazeutischer zwischenprodukte Active DE06722936T8 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78307606P 2006-03-17 2006-03-17
US783076P 2006-03-17
PCT/DK2006/000244 WO2007082533A1 (en) 2006-03-17 2006-05-08 Isomerisation of pharmaceutical intermediates

Publications (2)

Publication Number Publication Date
DE06722936T1 DE06722936T1 (de) 2008-02-07
DE06722936T8 true DE06722936T8 (de) 2008-06-05

Family

ID=37566638

Family Applications (1)

Application Number Title Priority Date Filing Date
DE06722936T Active DE06722936T8 (de) 2006-03-17 2006-05-08 Isomerisation pharmazeutischer zwischenprodukte

Country Status (14)

Country Link
US (1) US20070215455A1 (de)
EP (1) EP1844010B1 (de)
JP (2) JP5204088B2 (de)
CN (1) CN101400649B (de)
BR (1) BRPI0621471A2 (de)
CA (1) CA2646856C (de)
DE (1) DE06722936T8 (de)
ES (1) ES2406735T3 (de)
HK (1) HK1125623A1 (de)
IL (1) IL186074A (de)
MX (1) MX2008011557A (de)
RU (1) RU2412165C2 (de)
TW (1) TWI347935B (de)
WO (1) WO2007082533A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
AU2006253913B2 (en) 2005-06-01 2010-09-16 Mayne Pharma Llc Vitamin formulation
ES2272198B1 (es) * 2006-12-28 2008-06-01 Laboratorios Viñas S.A. Procedimiento para la obtencion de hidrato de calcipotriol.
CN101607932B (zh) * 2009-07-23 2012-05-09 青岛正大海尔制药有限公司 一种光化学反应制备骨化三醇的方法及其装置
EP2613632A1 (de) * 2010-09-10 2013-07-17 Genzyme Corporation Kontinuierliches photolytisches verfahren zur herstellung von vitamin-d-haltigen stoffen
EP2751113B1 (de) 2011-08-29 2017-07-05 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Verfahren und vorrichtung zur synthese von artemisinin
ES2411834B1 (es) * 2011-12-30 2014-03-18 Laboratorios Viñas S.A. Proceso industrial para obtener intermedios aptos para la síntesis de análogos de Vitamina D
WO2014140642A1 (en) 2013-03-15 2014-09-18 Veryan Medical Limited Stent apparatus and treatment methods
CN103694156B (zh) * 2014-01-07 2015-09-02 成都医路康医学技术服务有限公司 一种银屑病治疗药物钙泊三醇的制备方法
CN105753758B (zh) * 2014-12-17 2017-11-03 上虞京新药业有限公司 卡泊三醇的制备方法
WO2016100892A1 (en) * 2014-12-18 2016-06-23 Nucelis Llc Methods for improved production of vitamins d2 and d3
CN106908524B (zh) * 2015-12-23 2021-05-04 重庆华邦胜凯制药有限公司 卡泊三醇中间体l及其潜在基因毒性杂质的分离与测定方法
CN107033017B (zh) * 2017-04-25 2018-11-13 四川大学 一种快速制备高纯度羟基-γ-山椒素的方法
EP3888784A1 (de) * 2020-03-31 2021-10-06 Signify Holding B.V. Verbesserter kontinuierlicher durchlaufreaktor für photochemische prozesse mit konkav gewölbten seiten
DE102021132074A1 (de) * 2021-12-06 2023-06-07 EKATO Rühr- und Mischtechnik GmbH Reaktorvorrichtung und Verfahren zur Durchführung photochemischer Reaktionen mit einer Reaktorvorrichtung
DE102021132073A1 (de) * 2021-12-06 2023-06-07 EKATO Rühr- und Mischtechnik GmbH Photoreaktorvorrichtung und Verfahren zum Betrieb einer Photoreaktorvorrichtung

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3554887A (en) 1966-03-16 1971-01-12 Du Pont Photochemical apparatus and process
US4087342A (en) 1976-12-22 1978-05-02 Monsanto Company Method of simultaneously carrying out plurality of photochemical reactions
DE2735550A1 (de) 1977-08-06 1979-02-08 Guenther O Prof Dr Schenck Mehrkammer-photoreaktor
DE2904242A1 (de) 1979-02-05 1980-08-14 Guenther O Prof Dr Schenck Verfahren und vorrichtung zur reinigung, insbesondere zur entkeimung und desinfektion
US4456512A (en) 1982-03-10 1984-06-26 The Dow Chemical Company Photochemical reactor and method
US4454835A (en) 1982-09-13 1984-06-19 The United States Of America As Represented By The Secretary Of The Navy Internal photolysis reactor
US4866048A (en) 1985-08-02 1989-09-12 Leo Pharmaceutical Products Ltd. Novel vitamin D analogues
DE3625006A1 (de) 1985-10-26 1987-04-30 Basf Ag Photoreaktor fuer photochemische synthesen
US5012106A (en) 1988-12-23 1991-04-30 Gte Products Corporation Axi-symmetrical flow reactor for 196 Hg photochemical enrichment
US5126111A (en) 1990-12-05 1992-06-30 Nutech Energy Systems Inc. Fluid purification
USRE39706E1 (en) 1993-01-15 2007-06-26 Leo Pharma A/S Crystalline form of a vitamin D analogue
US5696380A (en) 1995-05-09 1997-12-09 Labatt Brewing Company Limited Flow-through photo-chemical reactor
RS52182B (sr) 1999-04-23 2012-10-31 Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) Farmaceutski preparat
JP3820070B2 (ja) * 1999-12-13 2006-09-13 帝人株式会社 プレビタミンｄ類合成用反応装置
IL153378A0 (en) 2000-07-18 2003-07-06 Bone Care Internat Inc STABILIZED 1alpha-HYDROXY VITAMIN D
AU9163701A (en) 2000-10-27 2002-05-06 Leo Pharma As Topical composition containing at least one vitamin D or one vitamin D analogue and at least one corticosteroid
DE10236717B4 (de) 2001-08-07 2006-04-20 Gudernatsch, Willi, Dr.-Ing. Vorrichtung zur Durchführung von photoreaktiven Prozessen bei einem Fluid
CA2489593C (en) 2002-06-13 2009-09-29 Teva Pharmaceutical Industries Ltd Epimerization of analogs of vitamin d
KR20050055784A (ko) * 2002-10-23 2005-06-13 레오 파마 에이/에스 비타민 디 유사체, 이 유사체를 포함하는 조성물 및 이들의용도
US7351869B2 (en) 2002-11-18 2008-04-01 Teva Pharmaceutical Industries Ltd Crystallization method for purification of calcipotriene
KR100859277B1 (ko) 2004-03-18 2008-09-19 레오 파마 에이/에스 비타민 ｄ 유사체의 입체선택적 합성
WO2005095336A2 (en) 2004-04-02 2005-10-13 Leo Pharma A/S Novel method for the preparation of intermediates useful for the synthesis of vitamin d analogues

Also Published As

Publication number Publication date
RU2412165C2 (ru) 2011-02-20
RU2008141150A (ru) 2010-04-27
CA2646856C (en) 2013-05-07
CN101400649A (zh) 2009-04-01
WO2007082533A1 (en) 2007-07-26
MX2008011557A (es) 2008-12-09
EP1844010B1 (de) 2013-02-13
JP2013056898A (ja) 2013-03-28
EP1844010A1 (de) 2007-10-17
ES2406735T3 (es) 2013-06-07
BRPI0621471A2 (pt) 2012-09-11
US20070215455A1 (en) 2007-09-20
HK1125623A1 (en) 2009-08-14
TWI347935B (en) 2011-09-01
JP2009530317A (ja) 2009-08-27
CN101400649B (zh) 2012-07-04
CA2646856A1 (en) 2007-07-26
IL186074A (en) 2011-11-30
TW200736208A (en) 2007-10-01
DE06722936T1 (de) 2008-02-07
JP5204088B2 (ja) 2013-06-05

Similar Documents

Publication Publication Date Title
DE06722936T8 (de) Isomerisation pharmazeutischer zwischenprodukte
LTC2140867I2 (lt) Farmacinė kompozicija
DK2384754T3 (da) Farmaceutiske doseringsformer
BRPI0715712A2 (pt) Composição farmacêutica
DK2041139T3 (da) Farmaceutiske forbindelser
BRPI0719393A2 (pt) Composição farmacêutica
BRPI0721651A2 (pt) Composição farmacêutica
DK2073795T3 (da) Misbrugssikret lægemiddelformulation
FR2896964B1 (fr) Boitier distributeur de produits cosmetiques
DK2344198T3 (da) Lipidbaserede farmaceutiske præparater til topisk anvendelse
UA14280S (uk) Футляр для косметичного виробу
BRPI0820381A2 (pt) Formulações farmacêuticas
DK3492069T3 (da) Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid
DK2034951T3 (da) Rehydererbart farmaceutisk produkt
BRPI0720234A2 (pt) Composição farmacêutica
BRPI0716445A2 (pt) composiÇço farmacÊutica
DK2120884T3 (da) Farmaceutisk sammensætning
BRPI0820198A2 (pt) composições farmacêuticas
BRPI0912656A2 (pt) formulação farmacêutica sólida
FI20065456A0 (fi) Maitotuotteiden rakenteen parantaminen
FI20086024A0 (fi) Uusi farmaseuttinen tuote
BRPI0820839A2 (pt) Composição farmacêutica
FR2951945B1 (fr) Composition pharmaceutique
IS8587A (is) Atorvastatin lyfjasamsetning
IS8660A (is) Gliklasíð lyfjasamsetning

Legal Events

Date Code Title Description
8596 Reprint of erroneous front page